Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells-Reference-Cited by-同舟云学术

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

Published:2001-05 Issue:5 Volume:15 Page:787-793
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Eriksen KW,Kaltoft K,Mikkelsen G,Nielsen M,Zhang Q,Geisler C,Nissen MH,Röpke C,Wasik MA,Ødum N

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402093.pdf

Reference28 articles.

1. Weinstock MA, Horm JW . Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology JAMA 1988 260: 42–46

2. Hansen ER . Immunoregulatory events in the skin of patients with cutaneous T cell lymphoma Arch Dermatol 1996 132: 554–561

3. Hansen ER, Vejlsgaard GL, Cooper KD, Heidenheim M, Larsen JK, Ho VC, Ross CW, Fox DA, Thomsen K, Baadsgaard O . Leukemic T cells from patients with cutaneous T cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T cell antigen receptor complex J Invest Dermatol 1993 100: 667–673

4. Kaltoft K, Bisballe S, Dyrberg T, Boel E, Rasmussen PB, Thestrup-Pedersen K . Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides In Vitro Cell Dev Biol 1992 28A: 161–167

5. Kaltoft K . Cytokine-driven immortalization of in vitro activated human T lymphocytes. CD28 expression correlates inversely with cell population doublings Exp Clin Immunogenet 1998 15: 84–89

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma;Journal of Investigative Dermatology;2024-07

2. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression;Blood Advances;2024-06-13

3. New JAK3-INSL3 Fusion Transcript—An Oncogenic Event in Cutaneous T-Cell Lymphoma;Cells;2023-09-29

4. Differential Response of Mycosis Fungoides Cells to Vorinostat;International Journal of Molecular Sciences;2023-04-29

5. Harnessing the immune system in the treatment of cutaneous T cell lymphomas;Frontiers in Oncology;2023-01-12